Biomerica (NASDAQ:BMRA) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened

Biomerica, Inc. (NASDAQ:BMRA) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.36 and traded as low as $0.27. Biomerica shares last traded at $0.33, with a volume of 377,159 shares changing hands.

Biomerica Price Performance

The business’s 50 day moving average price is $0.33 and its 200 day moving average price is $0.36. The firm has a market cap of $5.31 million, a PE ratio of -0.85 and a beta of -1.10.

Biomerica (NASDAQ:BMRA) last announced its earnings results on Tuesday, October 15th. The company reported ($0.08) EPS for the quarter. The firm had revenue of $1.81 million for the quarter. Biomerica had a negative net margin of 111.89% and a negative return on equity of 84.62%.

Institutional Trading of Biomerica

An institutional investor recently bought a new position in Biomerica stock. Perritt Capital Management Inc purchased a new stake in Biomerica, Inc. (NASDAQ:BMRA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 70,000 shares of the company’s stock, valued at approximately $31,000. Perritt Capital Management Inc owned 0.42% of Biomerica at the end of the most recent reporting period. Institutional investors own 22.28% of the company’s stock.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.